Archive for March 2017

Aldeyra Reports Full Year 2016 Financial Results

By Sam | March 30, 2017

LEXINGTON, MA–(Marketwired – March 30, 2017) – Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a biotechnology company focused primarily on the development of new products for inflammation, inborn errors of metabolism, and other diseases that are thought to be related to endogenously generated toxic… Source: BioSpace

Read More

Former Pfizer Neuroscientist to Helm New York Biotech

By Sam | March 30, 2017

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815×430-vencerx-robert-ring.jpg" NAME"Former Pfizer Neuroscientist to Helm New York Biotech Vencerx" ALT"Former Pfizer Neuroscientist to Helm New York Biotech Vencerx"March 31, 2017By Mark Terry, BioSpace.com Breaking News Staff… Source: BioSpace

Read More

2 Biotechs That May Disappear by 2020

By Sam | March 30, 2017

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815×450-stocks2.jpg" NAME"2 Biotechs That May Disappear by 2020" ALT"2 Biotechs That May Disappear by 2020"March 31, 2017By Mark Terry, BioSpace.com Breaking News StaffBad things can happen to good companies. A good product… Source: BioSpace

Read More

3 Biotechs That Could be Taken Out This Quarter

By Sam | March 30, 2017

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815×450-stocks5.jpg" NAME"3 Biotechs That Could be Taken Out This Quarter" ALT"3 Biotechs That Could be Taken Out This Quarter"March 31, 2017By Mark Terry, BioSpace.com Breaking News StaffThe first quarter of 2017 was… Source: BioSpace

Read More